4
Changes in Ownership
Akebia Therapeutics, Inc. Filed Acc 0001209191-15-032676
Director sold 996 shares at $9.09 ($9,052)
- Director acquired 1,980 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Nash Duane · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2015-04-01 | Grant or award : show line 1 in the form | +1,980 | $9.51 | $18,830 | 13,012 | D |
| 2015-04-02 | Sale : show line 2 in the form | −996 | $9.09 | $9,052 | 12,016 | D |
| Open-market sales · 996 sh · avg $9.09 · $9,052 | ||||||
Loading xslF345X03/doc4.xml…